ASCO GU 2022 – Janssen Highlights Niraparib Combo Data
Eleni Efstathiou, MD, PhD, Section Chief of Genitourinary Medical Oncology at Houston Methodist Oncology Partners and an investigator on the Phase...
5347 articles
Eleni Efstathiou, MD, PhD, Section Chief of Genitourinary Medical Oncology at Houston Methodist Oncology Partners and an investigator on the Phase...
Mitzi Joi Williams, board-certified neurologist, fellowship-trained multiple sclerosis specialist and Founder and CEO of the Joi Life Wellness Group Mul...
Robyn Knecht, Director of Counseling Services at the Saint Joseph's Indian School in South Dakota discusses the school; equine therapy and the benefits ...
Robyn Knecht, Director of Counseling Services at the Saint Joseph's Indian School in South Dakota discusses the school; why Native Americans suffer disp...
Steve Sell, CEO of agilon health, the trusted partner empowering physicians to transform community health, and Andy Mueller, MD, CEO of MaineHealth, the...
The CDC’s Advisory Committee on Immunization Practices (ACIP) is currently reviewing enhanced influenza vaccines (EIV), which are shots recommended to...
Richard Johnson, MD, Gout Education Society board member and a professor of medicine at the University of Colorado discusses his new book "Nature Want...
Dave Rosa, President and CEO discusses NeuroOne, a medical technology company focused on the development and commercialization of minimally invasive and...
Neely Mozaffarian, M.D., Ph.D., is a Vice President and Autoantibody Pathway Area Leader for the Immunology Therapeutic Area at Janssen Research & Devel...
Jeff Skolnik, Senior Vice President of Clinical Development at INOVIO Pharmaceuticals, discusses the current research and development of a DNA vaccine f...